Harleysville, PA, United States of America

Danilo R Casimiro

USPTO Granted Patents = 8 (Patent Applications = 15)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 384(Granted Patents)

Company Filing History:

5 out of 2,405

Merck Sharp + Dohme Corp.

Years Active: 2004-2023

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11752206 - Herpes simplex virus vaccine (2023-09-12),

2. 11406706 - Lipid nanoparticle vaccine adjuvants and antigen delivery systems (2022-08-09),

3. 10821175 - Lipid nanoparticle vaccine adjuvants and antigen delivery systems (2020-11-03),

4. 10449243 - Dengue virus vaccine compositions and methods of use thereof (2019-10-22),

5. 8168757 - PD-1 binding proteins (2012-05-01),

6. 7709010 - Papillomavirus vaccine compositions (2010-05-04),

7. 6787351 - Adenovirus carrying gag gene HIV vaccine (2004-09-07),

8. 6733993 - Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications (2004-05-11),

Title: Danilo R Casimiro: Pioneering Innovations in Vaccine Technology

Introduction: Danilo R Casimiro, a prolific inventor based in Harleysville, PA (US), is renowned for his passion for innovation and unwavering commitment to excellence. His groundbreaking work has positioned him as a trailblazer in the world of inventors, serving as a source of inspiration for aspiring innovators worldwide.

Latest Patents: Among his impressive portfolio of 8 patents, Danilo's most recent contributions include the development of Herpes simplex virus (HSV) ribonucleic acid (RNA) vaccines. These vaccines, formulated as lipid nanoparticles comprising cationic lipids, demonstrate remarkable potential in combating the herpes simplex virus. Additionally, his lipid nanoparticle vaccine adjuvants and antigen delivery systems have shown enhanced immunogenicity of vaccine antigens, showcasing his pioneering approach to vaccine technology.

Career Highlights: Danilo's illustrious career has seen him make significant strides in the field of biotechnology. Notably, he has held pivotal roles at Merck Sharp & Dohme Corporation and Merck & Company, Inc., where his innovative work has contributed to the advancement of pharmaceutical research and development. His dedication to pushing the boundaries of science has solidified his reputation as a visionary inventor.

Collaborations: Throughout his career, Danilo has collaborated with esteemed professionals in the industry, including Andrew J Bett and Ling Chen. These collaborations have not only enriched his work but have also resulted in groundbreaking advancements in vaccine technology. By fostering relationships with like-minded innovators, Danilo has been able to harness collective expertise to drive innovation forward.

Conclusion: Danilo R Casimiro's extraordinary contributions to the field of biotechnology underscore his unwavering commitment to innovation. His inventive spirit, coupled with his relentless pursuit of excellence, continues to shape the landscape of vaccine technology. As a prominent figure in the world of inventors, Danilo's legacy serves as a testament to the power of innovation in catalyzing positive change.

This text is generated by artificial intelligence and may not be accurate.